CORE LABORATORIES INC (CLB) Stock Fundamental Analysis

NYSE:CLB • US21867A1051

18.33 USD
-0.09 (-0.49%)
At close: Feb 23, 2026
18.33 USD
0 (0%)
After Hours: 2/23/2026, 8:04:00 PM
Fundamental Rating

5

CLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 61 industry peers in the Energy Equipment & Services industry. CLB has only an average score on both its financial health and profitability. While showing a medium growth rate, CLB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year CLB was profitable.
  • CLB had a positive operating cash flow in the past year.
  • Each year in the past 5 years CLB has been profitable.
  • CLB had a positive operating cash flow in each of the past 5 years.
CLB Yearly Net Income VS EBIT VS OCF VS FCFCLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • With a decent Return On Assets value of 5.33%, CLB is doing good in the industry, outperforming 73.77% of the companies in the same industry.
  • CLB has a Return On Equity of 11.37%. This is in the better half of the industry: CLB outperforms 73.77% of its industry peers.
  • CLB's Return On Invested Capital of 8.59% is fine compared to the rest of the industry. CLB outperforms 73.77% of its industry peers.
  • CLB had an Average Return On Invested Capital over the past 3 years of 8.28%. This is below the industry average of 12.99%.
  • The last Return On Invested Capital (8.59%) for CLB is above the 3 year average (8.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.33%
ROE 11.37%
ROIC 8.59%
ROA(3y)5.63%
ROA(5y)4.73%
ROE(3y)13.38%
ROE(5y)12.66%
ROIC(3y)8.28%
ROIC(5y)7.52%
CLB Yearly ROA, ROE, ROICCLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1.3 Margins

  • CLB has a Profit Margin of 6.04%. This is in the better half of the industry: CLB outperforms 63.93% of its industry peers.
  • CLB's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 11.38%, CLB perfoms like the industry average, outperforming 59.02% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CLB has declined.
  • With a Gross Margin value of 20.69%, CLB is not doing good in the industry: 67.21% of the companies in the same industry are doing better.
  • CLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.38%
PM (TTM) 6.04%
GM 20.69%
OM growth 3Y6.08%
OM growth 5Y-2.63%
PM growth 3Y14.9%
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-2.17%
CLB Yearly Profit, Operating, Gross MarginsCLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
  • CLB has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CLB has been increased compared to 5 years ago.
  • CLB has a better debt/assets ratio than last year.
CLB Yearly Shares OutstandingCLB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CLB Yearly Total Debt VS Total AssetsCLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • The Debt to FCF ratio of CLB is 4.88, which is a neutral value as it means it would take CLB, 4.88 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.88, CLB is in line with its industry, outperforming 50.82% of the companies in the same industry.
  • A Debt/Equity ratio of 0.39 indicates that CLB is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.39, CLB perfoms like the industry average, outperforming 54.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.88
Altman-Z N/A
ROIC/WACC1.04
WACC8.29%
CLB Yearly LT Debt VS Equity VS FCFCLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • CLB has a Current Ratio of 2.07. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
  • CLB has a better Current ratio (2.07) than 60.66% of its industry peers.
  • CLB has a Quick Ratio of 1.57. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CLB (1.57) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.57
CLB Yearly Current Assets VS Current LiabilitesCLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

4

3. Growth

3.1 Past

  • CLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.64%.
  • Measured over the past years, CLB shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.77% on average per year.
  • CLB shows a small growth in Revenue. In the last year, the Revenue has grown by 0.51%.
  • CLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.56% yearly.
EPS 1Y (TTM)-13.64%
EPS 3Y9.43%
EPS 5Y-0.77%
EPS Q2Q%-4.55%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y2.45%
Revenue growth 5Y1.56%
Sales Q2Q%6.98%

3.2 Future

  • Based on estimates for the next years, CLB will show a very strong growth in Earnings Per Share. The EPS will grow by 20.48% on average per year.
  • The Revenue is expected to grow by 4.46% on average over the next years.
EPS Next Y11.59%
EPS Next 2Y7.46%
EPS Next 3Y21.51%
EPS Next 5Y20.48%
Revenue Next Year4.33%
Revenue Next 2Y-0.59%
Revenue Next 3Y5.49%
Revenue Next 5Y4.46%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 24.12, which indicates a rather expensive current valuation of CLB.
  • Based on the Price/Earnings ratio, CLB is valued a bit cheaper than the industry average as 68.85% of the companies are valued more expensively.
  • CLB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
  • CLB is valuated rather expensively with a Price/Forward Earnings ratio of 21.61.
  • CLB's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.75, CLB is valued a bit cheaper.
Industry RankSector Rank
PE 24.12
Fwd PE 21.61
CLB Price Earnings VS Forward Price EarningsCLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLB indicates a slightly more expensive valuation: CLB is more expensive than 70.49% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CLB.
Industry RankSector Rank
P/FCF 37.78
EV/EBITDA 12.68
CLB Per share dataCLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLB does not grow enough to justify the current Price/Earnings ratio.
  • CLB has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLB's earnings are expected to grow with 21.51% in the coming years.
PEG (NY)2.08
PEG (5Y)N/A
EPS Next 2Y7.46%
EPS Next 3Y21.51%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.21%, CLB is not a good candidate for dividend investing.
  • CLB's Dividend Yield is comparable with the industry average which is at 1.10.
  • With a Dividend Yield of 0.21, CLB pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.21%

5.2 History

  • The dividend of CLB decreases each year by -32.16%.
  • CLB has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-32.16%
Div Incr Years0
Div Non Decr Years3
CLB Yearly Dividends per shareCLB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • CLB pays out 5.88% of its income as dividend. This is a sustainable payout ratio.
DP5.88%
EPS Next 2Y7.46%
EPS Next 3Y21.51%
CLB Yearly Income VS Free CF VS DividendCLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M
CLB Dividend Payout.CLB Dividend Payout, showing the Payout Ratio.CLB Dividend Payout.PayoutRetained Earnings

CORE LABORATORIES INC

NYSE:CLB (2/23/2026, 8:04:00 PM)

After market: 18.33 0 (0%)

18.33

-0.09 (-0.49%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-04
Earnings (Next)N/A
Inst Owners113.63%
Inst Owner Change-0.67%
Ins Owners1.02%
Ins Owner Change7.43%
Market Cap853.44M
Revenue(TTM)526.52M
Net Income(TTM)31.80M
Analysts48
Price Target16.15 (-11.89%)
Short Float %9.23%
Short Ratio11.34
Dividend
Industry RankSector Rank
Dividend Yield 0.21%
Yearly Dividend0.04
Dividend Growth(5Y)-32.16%
DP5.88%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.53%
Min EPS beat(2)10.2%
Max EPS beat(2)12.86%
EPS beat(4)2
Avg EPS beat(4)4.52%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)5
Avg EPS beat(8)6.38%
EPS beat(12)7
Avg EPS beat(12)5.91%
EPS beat(16)9
Avg EPS beat(16)4.12%
Revenue beat(2)2
Avg Revenue beat(2)2.93%
Min Revenue beat(2)1.44%
Max Revenue beat(2)4.41%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)4.41%
Revenue beat(8)4
Avg Revenue beat(8)0.13%
Revenue beat(12)5
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.87%
PT rev (1m)0%
PT rev (3m)3.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20.87%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 24.12
Fwd PE 21.61
P/S 1.62
P/FCF 37.78
P/OCF 22.96
P/B 3.05
P/tB 14.47
EV/EBITDA 12.68
EPS(TTM)0.76
EY4.15%
EPS(NY)0.85
Fwd EY4.63%
FCF(TTM)0.49
FCFY2.65%
OCF(TTM)0.8
OCFY4.36%
SpS11.31
BVpS6.01
TBVpS1.27
PEG (NY)2.08
PEG (5Y)N/A
Graham Number10.14
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 11.37%
ROCE 12.23%
ROIC 8.59%
ROICexc 9.01%
ROICexgc 17.09%
OM 11.38%
PM (TTM) 6.04%
GM 20.69%
FCFM 4.29%
ROA(3y)5.63%
ROA(5y)4.73%
ROE(3y)13.38%
ROE(5y)12.66%
ROIC(3y)8.28%
ROIC(5y)7.52%
ROICexc(3y)8.61%
ROICexc(5y)7.81%
ROICexgc(3y)12.8%
ROICexgc(5y)11.12%
ROCE(3y)11.79%
ROCE(5y)10.71%
ROICexgc growth 3Y22.55%
ROICexgc growth 5Y6.53%
ROICexc growth 3Y8.12%
ROICexc growth 5Y-1.19%
OM growth 3Y6.08%
OM growth 5Y-2.63%
PM growth 3Y14.9%
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-2.17%
F-Score7
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.88
Debt/EBITDA 1.48
Cap/Depr 99.59%
Cap/Sales 2.77%
Interest Coverage 250
Cash Conversion 49.87%
Profit Quality 71.02%
Current Ratio 2.07
Quick Ratio 1.57
Altman-Z N/A
F-Score7
WACC8.29%
ROIC/WACC1.04
Cap/Depr(3y)84.58%
Cap/Depr(5y)77.2%
Cap/Sales(3y)2.44%
Cap/Sales(5y)2.46%
Profit Quality(3y)82.62%
Profit Quality(5y)88.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.64%
EPS 3Y9.43%
EPS 5Y-0.77%
EPS Q2Q%-4.55%
EPS Next Y11.59%
EPS Next 2Y7.46%
EPS Next 3Y21.51%
EPS Next 5Y20.48%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y2.45%
Revenue growth 5Y1.56%
Sales Q2Q%6.98%
Revenue Next Year4.33%
Revenue Next 2Y-0.59%
Revenue Next 3Y5.49%
Revenue Next 5Y4.46%
EBIT growth 1Y-1.42%
EBIT growth 3Y8.67%
EBIT growth 5Y-1.11%
EBIT Next Year27.9%
EBIT Next 3Y31.2%
EBIT Next 5Y23.36%
FCF growth 1Y-47.91%
FCF growth 3Y15.13%
FCF growth 5Y-13.26%
OCF growth 1Y-34.07%
OCF growth 3Y14.14%
OCF growth 5Y-8.48%

CORE LABORATORIES INC / CLB FAQ

Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?

ChartMill assigns a fundamental rating of 5 / 10 to CLB.


Can you provide the valuation status for CORE LABORATORIES INC?

ChartMill assigns a valuation rating of 3 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.


Can you provide the profitability details for CORE LABORATORIES INC?

CORE LABORATORIES INC (CLB) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CLB stock?

The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 24.12 and the Price/Book (PB) ratio is 3.05.


What is the expected EPS growth for CORE LABORATORIES INC (CLB) stock?

The Earnings per Share (EPS) of CORE LABORATORIES INC (CLB) is expected to grow by 11.59% in the next year.